Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical finished formulations and products in India and internationally. It is involved in trading of active pharmaceutical ingredient, as well as provides technical consultancy services to various distributors and contract manufacturing services. The company offers capsule, cream, eye drop, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, and tablets. It has operations in Bhutan, Bolivia, Chile, Costa Rica, Cuba, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Kuwait, Madagascar, Malaysia, Hong Kong, Myanmar, Panama, Trinidad and Tobago, Uzbekistan, Venezuela, and Vietnam. The company was formerly known as Remus Pharmaceuticals Private Limited and changed its name to Remus Pharmaceuticals Limited in January 2023. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.
Metrics to compare | REMP | Peers Peers - average of corresponding metrics from companies closely matching REMP: 542934, MAITREYA, 536565, KRSNAA, INDRAMEDCO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipREMPPeersSector |
---|---|---|---|---|
P/E Ratio | 37.4x | 25.4x | −0.5x | |
PEG Ratio | - | 0.07 | 0.00 | |
Price/Book | 11.1x | 2.7x | 2.6x | |
Price / LTM Sales | 2.5x | 2.3x | 2.9x | |
Upside (Analyst Target) | - | 64.7% | 53.0% | |
Fair Value Upside | Unlock | 3.1% | 8.9% | Unlock |